Fennec Pharmaceuticals CEO sells over 437k in company stock
FENC Stock | USD 7.04 0.08 1.12% |
About 62% of Fennec Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Fennec Pharmaceuticals stock suggests that many investors are alarmed at this time. Fennec Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Fennec Pharmaceuticals. The current market sentiment, together with Fennec Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Fennec Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Fennec Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fennec daily returns and investor perception about the current price of Fennec Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Fennec |
Fennec Pharmaceuticals CEO sells over 437k in company stock
Read at investing.com
Fennec Pharmaceuticals Fundamental Analysis
We analyze Fennec Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fennec Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fennec Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Fennec Pharmaceuticals is currently under evaluation in net income category among related companies. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Fennec Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fennec Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Fennec Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Fennec Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Fennec Pharmaceuticals Related Equities
OBIO | Orchestra BioMed | 12.77 | ||||
ANEB | Anebulo Pharmaceuticals | 4.07 | ||||
IKNA | Ikena Oncology | 2.14 | ||||
OLMA | Olema Pharmaceuticals | 1.86 | ||||
ELYM | Eliem Therapeutics | 0.86 | ||||
IRON | Disc Medicine | 0.81 | ||||
EWTX | Edgewise Therapeutics | 0.39 | ||||
CSBR | Champions Oncology | 0.63 | ||||
LRMR | Larimar Therapeutics | 0.67 | ||||
MNOV | MediciNova | 0.70 | ||||
JANX | Janux Therapeutics | 0.86 | ||||
HRMY | Harmony Biosciences | 0.96 | ||||
MOLN | Molecular Partners | 2.33 | ||||
KROS | Keros TherapeuticsInc | 3.17 | ||||
AVTE | Aerovate Therapeutics | 6.12 |
Check out Fennec Pharmaceuticals Hype Analysis, Fennec Pharmaceuticals Correlation and Fennec Pharmaceuticals Performance. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.